Clinical Study of a Diagnostic Device for NG, TV and CT in Women

NACompletedINTERVENTIONAL
Enrollment

1,585

Participants

Timeline

Start Date

February 27, 2019

Primary Completion Date

December 2, 2019

Study Completion Date

December 2, 2019

Conditions
Chlamydial InfectionGonococcal InfectionTrichomoniasis
Interventions
DEVICE

Click Device

A single-use device containing a polymerase chain reaction (PCR)-based nucleic acid amplification test (NAAT) for detection of deoxyribonucleic acid (DNA) from Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) in self-collected vaginal specimens.

Trial Locations (10)

19145

Philadelphia Department of Public Health - Health Center 1, Philadelphia

21205

Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore

33016

South Florida Clinical Trials, Hialeah

33199

Florida International University - Student Health Center, Miami

39202

University of Mississippi - Infectious Diseases, Jackson

60612

Cook County Health and Hospitals System - Ruth M Rothstein CORE Center, Chicago

89106

Impact Clinical Trials, Las Vegas

90036

Axis Clinical Trials, Los Angeles

92103-8208

University of California, San Diego - Antiviral Research Center, San Diego

94103-4030

San Francisco Department of Public Health - San Francisco City Clinic, San Francisco

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03852316 - Clinical Study of a Diagnostic Device for NG, TV and CT in Women | Biotech Hunter | Biotech Hunter